Skip to content
Screener

Veradermics MANE Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Hims & Hers Health logo
Hims & Hers HealthHIMS
6%-0.8pp
PVL
Palvella TherapeuticsPVLA
$528K
TTR
Turn Therapeutics Inc.TTRX
$67.57K
PTH
Pelthos TherapeuticsPTHS
8.4%
Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
$5.39M-14.7%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
9.7%+0.1pp

Other financials

Income statement

See full
Operating income-$29.9M-131%
Net income-$27.2M-120%
EPS (diluted)-$1.32+93.3%

Balance sheet

See full
Cash & equivalents$168.4M+419%
Total debt$4.0K
Total equity$390.6M+744%
Total assets$397.4M

Cash flow

See full
Operating cash flow-$21.2M-59.0%
CapEx--100%
Free cash flow-$21.2M-58.7%

Valuation

See full
Market cap$4.54B+261%

Returns & leverage

See full
Return on equity-28.7%
Current ratio59.1×

Where this comes from

Reported directly by Veradermics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Veradermics’s 10-K, filed March 30, 2026.

Filed
Mar 30, 2026, 5:35 PM EDT
Fiscal year
FY2025
Accession
0001827635-26-000013
(in thousands, except share and per share amounts)As of December 31, 2025As of December 31, 2024
Total current assets152,49455,535
Long-term assets:
Property, plant and equipment, net22
Right-of-use asset and other long-term assets103
Total non-current assets125
Total assets$152,619$55,535
Liabilities and stockholders’ deficit
Current liabilities:

Item 16. Form 10-K Summary

FAQ

What is Veradermics's operating lease ROU assets?
Veradermics (MANE) reported operating lease ROU assets of $103K in Q4 2025.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Veradermics's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude